<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medvis</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская визуализация</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Visualization</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-0763</issn><issn pub-type="epub">2408-9516</issn><publisher><publisher-name>RDS-Media Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24835/1607-0763-2018-5-31-38</article-id><article-id custom-type="elpub" pub-id-type="custom">medvis-652</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МОЛОЧНАЯ ЖЕЛЕЗА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BREAST</subject></subj-group></article-categories><title-group><article-title>Рентгенологическая плотность структуры молочной железы как фактор риска развития протоковой карциномы in situ</article-title><trans-title-group xml:lang="en"><trans-title>Breast density as a risk factor of development of ductal carcinoma in situ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пучкова</surname><given-names>О. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Puchkova</surname><given-names>O. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-рентгенолог отделения лучевой диагностики</p><p>121059 Москва, Бережковская набережная, дом 16А, стр. 3</p></bio><bio xml:lang="en"><p>Breast imaging radiologist</p><p>Berezhkovskaya naberezhnaya, 16А-3-4, 121059, Moscow, Russian Federation</p></bio><email xlink:type="simple">helgasoul@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синицын</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinitsyn</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор мед. наук, профессор, заведующий кафедрой лучевой диагностики факультета фундаментальной медицины</p></bio><bio xml:lang="en"><p>doct. of med. sci., Professor, Head of Radiology Department and Chair of Radiology</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богомазова</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogomazova</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, заведующая отделением патоморфологии</p></bio><bio xml:lang="en"><p>cand. of med. sci., Head of Pathomorphology Department</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мершина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mershina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, заведующая отделением лучевой диагностики факультета фундаментальноймедицины</p></bio><bio xml:lang="en"><p>cand. of med. sci., Deputy of Radiology Department</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Широкий</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Shirokiy</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, заведующий отделением патологии молочной железы</p></bio><bio xml:lang="en"><p>Head of Breast Pathology Department</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баженова</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bazhenova</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирантка кафедры лучевой диагностики факультета фундаментальной медицины</p></bio><bio xml:lang="en"><p>Radiologist at Radiology Department</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ненайденко</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nenaydenko</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ординатор второго года обучения факультета фундаментальной медицины</p></bio><bio xml:lang="en"><p>Resident at Radiology Department</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Филиал компании с ограниченной ответственностью “Хадасса Медикал ЛТД”, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Hadassah Medical Skolkovo</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Факультет фундаментальной медицины Московского государственного университета имени М.В. Ломоносова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>University Hospital Lomonosov Moscow State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАУ “Лечебно-реабилитационный центр” Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Treatment and Rehabilitation center of Ministry of Health</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>28</day><month>10</month><year>2018</year></pub-date><volume>0</volume><issue>5</issue><fpage>31</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пучкова О.С., Синицын В.Е., Богомазова С.Ю., Мершина Е.А., Широкий В.П., Баженова Д.А., Ненайденко Е.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Пучкова О.С., Синицын В.Е., Богомазова С.Ю., Мершина Е.А., Широкий В.П., Баженова Д.А., Ненайденко Е.В.</copyright-holder><copyright-holder xml:lang="en">Puchkova O.S., Sinitsyn V.E., Bogomazova S.Y., Mershina E.A., Shirokiy V.P., Bazhenova D.A., Nenaydenko E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medvis.rdsmedia.ru/jour/article/view/652">https://medvis.rdsmedia.ru/jour/article/view/652</self-uri><abstract><p>Цель исследования: выявить потенциальную связь рентгенологической плотности структуры молочной железы, различных рентгенологических подтипов строения молочной железы и риском развития протоковой карциномы in situ.Материал и методы. В настоящем исследовании приняли участие 169 пациенток, разделенных на 2 группы в соответствии с современной рентгенологической классификацией L. Tabar. Всем пациенткам была выполнена трепан-биопсия с последующим гистологическим исследованием. 1-ю группу составили 57 (33,7%) женщин с опухолями, возникающими в терминальном секреторном отделе железы, – ацинарной аденокарциномой (AAB), унифокальной и мультифокальной формами, а 2-ю – 112 (66,3%) женщин с такими типами рака, как истинная протоковая аденокарцинома in situ (in situ DAB) и истинная протоковая аденокарцинома in situ, ассоциированная с ацинарной формой рака молочной железы (in situ DAB + AAB). Качество рентгенологического изображения оценивалось по классификации PGMI. Исследование было выполнено на цифровой маммографической системе производства General Electric. Оценка рентгенологической плотности структуры молочной железы выполнялась по классификации ACR 2013 г. Тип рентгенологического строения железы оценивался по классификации L. Tabar.Результаты. В соответствии с результатами про веденного анализа были установлены статистически значимые различия сравниваемых групп по рентгенологической плотности структуры молочной железы (p &lt; 0,001). В 1-й группе преобладали пациентки с плотностью ACR 1, доля которых составляла 52,6%. Во 2-й группе с наибольшей частотой отмечались случаи рент генологической плотности структуры ACR 4, доля которых среди всех исследуемых составляла 32,1%. Таким образом, был сделан вывод о более высокой рентгенологической плотности структуры молочной железы в группе пациенток с протоковой карциномой in situ (DAB).Заключение. Высокая рентгенологическая плотность структуры, а также IV и V типы строения молочной железы по классификации L. Tabar статистически связаны с повышенным риском развития протоковой карциномы in situ. Исследование показало статистически значимую разницу в возрасте возникновения протокового и ацинарного рака молочной железы (средний возраст пациенток составил 52 и 64 года соответственно).</p></abstract><trans-abstract xml:lang="en"><p>Objectives. to reveal a potential relationship between the breast density, various radiographic patterns of the breast structure, and the risk of developing ductal adenocarcinoma in situ.Methods. In this study, 169 patients were divided into 2 groups according to the modern X-ray classification L. Tabar. All patients underwent a core biopsy with subsequent histological examination. The first group consisted of 57 women (33.7%) with tumors arising in the terminal ductal-lobular unit – acinar adenocarcinoma (AAB) unifocal and multifocal forms, and the second group – 112 women (66.3%) with types of ductal adenocarcinoma in situ (in situ DAB) and ductal adenocarcinoma in situ associated with the acinar form of breast cancer (DAB + AAB). Pathologic findings on mammography were assessed using the modern classification of L. Tabar. Evaluation of the breast density was made using ACR 2013 classification. The Pattern of radiologic breast structure was evaluated according to the classification of L. Tabar.Results. According to our results, statistically significant differences of the compared groups on the breast density were established (p &lt; 0.001). In the first group, patients with a density of ACR 1 prevailed, the proportion of which was 52.6%. In the second group, the incidence of ACR 4 was highest, with a share of 32.1% among all patients. Thus, it was concluded that there is an association of the breast density ACR 3 and ACR 4 and risk of development of DAB.Conclusions. The high breast density, as well as the IV and V type of the breast structure according to L. Tabar's classification, are statistically associated with an increased risk of developing ductal carcinoma in situ (DAB). Our study also showed a statistically significant difference in the age of onset of ductal and acinar adenocarcinoma of the breast – 52 and 64, respectively.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рентгенологическая плотность структуры</kwd><kwd>маммография</kwd><kwd>протоковая карцинома in situ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>breast density</kwd><kwd>mammography</kwd><kwd>ductal adenocarcinoma in situ</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart B.W., Wild C.P., eds. World cancer report 2014. Lyon: International Agency for Research on Cancer; 2014.</mixed-citation><mixed-citation xml:lang="en">Stewart B.W., Wild C.P., eds. World cancer report 2014. Lyon: International Agency for Research on Cancer; 2014.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2013 году (Заболеваемость и смертность). М., 2015.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinskiy V.V., Petrova G.V. Malignant tumors in Russia in 2013 year (Morbidity and Mortality). Moscow, 2015. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tabar L., Fagerberg G., Duffy S.W., Day N.E. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J. Epidemiol. Community Health. 1989; 43 (2): 107–114.</mixed-citation><mixed-citation xml:lang="en">Tabar L., Fagerberg G., Duffy S.W., Day N.E. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J. Epidemiol. Community Health. 1989; 43 (2): 107–114.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sardanelli F., Aase H.S., Álvarez M. et al. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Eur. Radiol. 2017; 27 (7): 2737–2743. DOI: 10.1007/s00330-016-4612-z.</mixed-citation><mixed-citation xml:lang="en">Sardanelli F., Aase H.S., Álvarez M. et al. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Eur. Radiol. 2017; 27 (7): 2737–2743. DOI: 10.1007/s00330-016-4612-z.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Tabar L., Tot T., Peter B. D. Tarjan M. Prostate and Breast: brother and sister organs. Vol. II. 2013.</mixed-citation><mixed-citation xml:lang="en">Tabar L., Tot T., Peter B. D. Tarjan M. Prostate and Breast: brother and sister organs. Vol. II. 2013.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tabar L., Tot T., Peter B.D. Breast cancer: The art and science of early detection with mammography. 2005.</mixed-citation><mixed-citation xml:lang="en">Tabar L., Tot T., Peter B.D. Breast cancer: The art and science of early detection with mammography. 2005.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tabar L., Tot T., Peter B.D. Ductal adenocarcinoma of the breast (DAB). Vol. III, Part 1. 2014.</mixed-citation><mixed-citation xml:lang="en">Tabar L., Tot T., Peter B.D. Ductal adenocarcinoma of the breast (DAB). Vol. III, Part 1. 2014.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Engmann N.J., Golmakani M.K., Miglioretti D.L., Sprague B.L., Kerlikowske K. Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer. JAMA Oncol. 2017; 3 (9): 1228–1236. DOI:10.1001/jamaoncol.2016.6326.</mixed-citation><mixed-citation xml:lang="en">Engmann N.J., Golmakani M.K., Miglioretti D.L., Sprague B.L., Kerlikowske K. Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer. JAMA Oncol. 2017; 3 (9): 1228–1236. DOI:10.1001/jamaoncol.2016.6326.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Yaghjyan L., Colditz G.A., Collins L.C., Schnitt S.J., Rosner B., Vachon C., Tamimi R.M. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J. Natl. Cancer Inst. 2011; 103: 1179–1189. DOI: 10.1093/jnci/djr225.</mixed-citation><mixed-citation xml:lang="en">Yaghjyan L., Colditz G.A., Collins L.C., Schnitt S.J., Rosner B., Vachon C., Tamimi R.M. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J. Natl. Cancer Inst. 2011; 103: 1179–1189. DOI: 10.1093/jnci/djr225.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Carver Е., Carver B., Medical Imaging Е-book: Techniques, Reflection and Evaluation. Elsevier , 2012. 11. Radisky D.C., Visscher D.W., Frank R.D., Vierkant R.A., Winham S., Stallings-Mann M., Hoskin T.L., Nassar A., Vachon C.M., Denison L.A., Hartmann L.C., Frost M.H., Degnim A.C. Natural history of age-related lobular involution and impact on breast cancer risk. Breast Cancer Res. Treat. 2013; 155: 423–430. DOI: 10.1007/s10549-016-3691-5.</mixed-citation><mixed-citation xml:lang="en">Carver Е., Carver B., Medical Imaging Е-book: Techniques, Reflection and Evaluation. Elsevier , 2012.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bodelon C., Oh H., Chatterjee N., Garcia-Closas M., Palakal M., Sherman M.E., Pfeiffer R.M., Geller B.M., Vacek P.M., Weaver D.L., Chicoine R.E., Papathomas D., Xiang J., Patel D.A., Khodr Z.G., Linville L., Clare S.E., Visscher D.W., Mies C., Hewitt S.M., Brinton L.A., Storniolo A.M., He C., Chanock S.J., Gierach G.L., Figueroa J.D. Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast. Int. J. Cancer. 2017; 140: 825–832. DOI: 10.1002/ijc.30512.</mixed-citation><mixed-citation xml:lang="en">Radisky D.C., Visscher D.W., Frank R.D., Vierkant R.A., Winham S., Stallings-Mann M., Hoskin  T.L., Nassar A., Vachon C.M., Denison L.A., Hartmann L.C., Frost M.H., Degnim A.C. Natural history of age-related lobular involution and impact on breast cancer risk. Breast Cancer Res. Treat. 2013; 155: 423–430. DOI: 10.1007/s10549-016-3691-5.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">DeFilippis R.A., Fordyce C., Patten K., Chang H., Zhao J., Fontenay G.V., Kerlikowske K., Parvin B., Tlsty T.D. Stress Signaling from Human Mammary Epithelial Cells Contributes to Phenotypes of Mammographic Density. Cancer Res. 2014; 74 (18): 5032–5044. DOI: 10.1158/0008-5472.CAN-13-3390.</mixed-citation><mixed-citation xml:lang="en">Bodelon C., Oh H., Chatterjee N., Garcia-Closas M., Palakal M., Sherman M.E., Pfeiffer R.M., Geller B.M., Vacek P.M., Weaver D.L., Chicoine R.E., Papathomas D., Xiang J., Patel D.A., Khodr Z.G., Linville L., Clare S.E., Visscher D.W., Mies C., Hewitt S.M., Brinton L.A., Storniolo A.M., He C., Chanock S.J., Gierach G.L., Figueroa J.D. Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast. Int. J. Cancer. 2017; 140: 825–832. DOI: 10.1002/ijc.30512.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">DeFilippis R.A., Fordyce C., Patten K., Chang H., Zhao J., Fontenay G.V., Kerlikowske K., Parvin B., Tlsty T.D. Stress Signaling from Human Mammary Epithelial Cells Contributes to Phenotypes of Mammographic Density. Cancer Res. 2014; 74 (18): 5032–5044. DOI: 10.1158/0008-5472.CAN-13-3390.</mixed-citation><mixed-citation xml:lang="en">DeFilippis R.A., Fordyce C., Patten K., Chang H., Zhao J., Fontenay G.V., Kerlikowske K., Parvin B., Tlsty T.D. Stress Signaling from Human Mammary Epithelial Cells Contributes to Phenotypes of Mammographic Density. Cancer Res. 2014; 74 (18): 5032–5044. DOI: 10.1158/0008-5472.CAN-13-3390.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
